DUBLIN, Ohio, Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2024 to shareholders of record at the close of business on April 1, 2024.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With more than 50 years in business, operations in more than 30 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at www.cardinalhealth.com.
Contacts
Media: Erich Timmerman, This email address is being protected from spambots. You need JavaScript enabled to view it. and 614.757.8231
Investors: Matt Sims, This email address is being protected from spambots. You need JavaScript enabled to view it. and 614.553.3661
| Last Trade: | US$119.14 |
| Daily Change: | -0.06 -0.05 |
| Daily Volume: | 1,007,922 |
| Market Cap: | US$28.830B |
November 20, 2024 November 11, 2024 November 01, 2024 October 29, 2024 September 20, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
